Does peritransplantation use of rituximab reduce the risk of EBV reactivation and PTLPD?-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Does peritransplantation use of rituximab reduce the risk of EBV reactivation and PTLPD?

Published:2009-06-11 Issue:24 Volume:113 Page:6263-6264
ISSN:0006-4971
Container-title:Blood
language:en
Short-container-title:

Author:

Savani Bipin N.,Pohlmann Paula R.,Jagasia Madan,Chinratanalab Wichai,Kassim Adetola,Engelhardt Brian,Greer John,Schuening Friedrich,Goodman Stacey

Publisher

American Society of Hematology

Subject

Cell Biology,Hematology,Immunology,Biochemistry

Link

http://ashpublications.org/blood/article-pdf/113/24/6263/1311018/zh802409006263.pdf

Reference12 articles.

1. Risk factors for lymphoproliferative disorders after allogeneic hematopoietic cell transplantation.;Landgren;Blood,2009

2. Preemptive rituximab treatment may reduce the incidence of post-transplant lymphoproliferative disorders (PTLD) in patients with EBV reactivation after allogeneic stem cell transplantation [abstract].;Kindwall-Keller;Biol Blood Marrow Transplant,2009

3. Induction immunosuppression with thymoglobulin and rituximab in intestinal and multivisceral transplantation.;Vianna;Transplantation,2008

4. Hypogammaglobulinemia with a selective delayed recovery in memory B cells and an impaired isotype expression after rituximab administration as an adjuvant to autologous stem cell transplantation for non-Hodgkin lymphoma.;Nishio;Eur J Haematol,2006

5. Reduced-intensity regimens in allogeneic stem-cell transplantation for non-Hodgkin lymphoma and chronic lymphocytic leukemia.;Khouri;Hematology Am Soc Hematol Educ Program,2006

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Post‐transplant lymphoproliferative disorder: Update on treatment and novel therapies;British Journal of Haematology;2023-03-22

2. Pre-Hematopoietic Stem Cell Transplantation Rituximab for Epstein-Barr Virus and Post-Lymphoproliferative Disorder Prophylaxis in Alemtuzumab Recipients;Transplantation and Cellular Therapy;2023-02

3. An Unusual Cause of Acute Pancreatitis in a Liver Transplant Recipient;Transplantation Direct;2021-04-27

4. Management of PTLD After Hematopoietic Stem Cell Transplantation: Immunological Perspectives;Frontiers in Immunology;2020-09-16

5. Low incidence of posttransplant lymphoproliferative disorder after allogeneic stem cell transplantation in patients with lymphoma treated with rituximab;Hematological Oncology;2020-02-03

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3